0.6846
price down icon2.20%   -0.0154
after-market Handel nachbörslich: .69 0.0054 +0.79%
loading

Xilio Therapeutics Inc Aktie (XLO) Neueste Nachrichten

pulisher
03:10 AM

Should you wait for a breakout in Xilio Therapeutics Inc.July 2025 EndofMonth & Risk Controlled Daily Trade Plans - Newser

03:10 AM
pulisher
02:27 AM

Can momentum traders help lift Xilio Therapeutics Inc.CEO Change & Weekly Return Optimization Alerts - Newser

02:27 AM
pulisher
09:31 AM

Risk adjusted return profile for Xilio Therapeutics Inc. analyzedEarnings Overview Report & Real-Time Buy Zone Alerts - Newser

09:31 AM
pulisher
08:02 AM

How to use Fibonacci retracement on Xilio Therapeutics Inc.Quarterly Profit Review & AI Powered Market Trend Analysis - Newser

08:02 AM
pulisher
07:59 AM

Using Bollinger Bands to evaluate Xilio Therapeutics Inc.Weekly Trade Summary & Community Consensus Trade Signals - Newser

07:59 AM
pulisher
07:40 AM

What makes Xilio Therapeutics Inc. stock price move sharplyEarnings Risk Report & Weekly Top Stock Performers List - Newser

07:40 AM
pulisher
06:24 AM

Analyzing net buyer seller activity in Xilio Therapeutics Inc.Portfolio Return Summary & Weekly Stock Breakout Alerts - Newser

06:24 AM
pulisher
01:36 AM

Advanced analytics toolkit walkthrough for Xilio Therapeutics Inc.2025 AllTime Highs & Detailed Earnings Play Alerts - Newser

01:36 AM
pulisher
12:57 PM

Xilio Therapeutics Inc. Stock Poised for Technical Comeback getLinesFromResByArray error: size == 0 - 더경남뉴스

12:57 PM
pulisher
Aug 26, 2025

Can you recover from losses in Xilio Therapeutics Inc.2025 Stock Rankings & Technical Pattern Based Signals - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

What to do if you’re stuck in Xilio Therapeutics Inc.Earnings Summary Report & High Accuracy Buy Signal Tips - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Xilio Therapeutics Inc. Shows Early Signs of Technical Strength getLinesFromResByArray error: size == 0 - kangso.co.kr

Aug 26, 2025
pulisher
Aug 26, 2025

Can Xilio Therapeutics Inc. rally from current levels2025 AllTime Highs & Verified Short-Term Plans - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Visual trend scoring systems applied to Xilio Therapeutics Inc.Oil Prices & Reliable Entry Point Trade Alerts - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

What indicators show strength in Xilio Therapeutics Inc.July 2025 Momentum & Community Supported Trade Ideas - Newser

Aug 26, 2025
pulisher
Aug 25, 2025

Xilio Therapeutics Inc. Enters Reversal Setup in Weekly ChartsStop Loss & Precise Entry and Exit Recommendations - newsyoung.net

Aug 25, 2025
pulisher
Aug 24, 2025

Analyzing drawdowns of Xilio Therapeutics Inc. with statistical toolsShare Buyback & Consistent Return Strategy Ideas - Newser

Aug 24, 2025
pulisher
Aug 24, 2025

How to read the order book for Xilio Therapeutics Inc.Trade Risk Report & Safe Entry Trade Signal Reports - Newser

Aug 24, 2025
pulisher
Aug 23, 2025

Can Xilio Therapeutics Inc. deliver consistent dividendsTrade Performance Summary & Verified Momentum Stock Ideas - theviewers.co.kr

Aug 23, 2025
pulisher
Aug 23, 2025

Moving Averages: Does Xilio Therapeutics Inc. have strong fundamentals2025 Winners & Losers & Community Consensus Trade Alerts - theviewers.co.kr

Aug 23, 2025
pulisher
Aug 21, 2025

Is Xilio Therapeutics Inc.’s ROE strong enough2025 Geopolitical Influence & Weekly High Return Stock Opportunities - theviewers.co.kr

Aug 21, 2025
pulisher
Aug 20, 2025

Technical Models Suggest Xilio Therapeutics Inc. May Rebound Soon2025 Market Overview & Expert Verified Movement Alerts - mustnews.co.kr

Aug 20, 2025
pulisher
Aug 20, 2025

Xilio Therapeutics' Q2 Earnings Show Promising Pipeline Progress and Strong Financial Position - AInvest

Aug 20, 2025
pulisher
Aug 19, 2025

Xilio Therapeutics Reports Strong Pipeline Progress and Financial Results - The Globe and Mail

Aug 19, 2025
pulisher
Aug 19, 2025

Technical analysis overview for Xilio Therapeutics Inc. stockWeekly Trade Summary & AI Optimized Trading Strategy Guides - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Can trapped investors hope for a rebound in Xilio Therapeutics Inc.Quarterly Portfolio Summary & Growth Oriented Trading Recommendations - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Xilio Therapeutics Reports Q2 Earnings with Promising Pipeline Progress and Financial Results - AInvest

Aug 19, 2025
pulisher
Aug 18, 2025

Xilio Therapeutics Q2 2025 Earnings Miss Fails to Deliver, but Short-Term Price Action Shows Promise - AInvest

Aug 18, 2025
pulisher
Aug 17, 2025

Xilio Therapeutics Q2 2025 Earnings Miss: Mixed Market Impact Amid Biotech Sector Resilience - AInvest

Aug 17, 2025
pulisher
Aug 16, 2025

Will Xilio Therapeutics Inc. rebound enough to break evenWeekly Loss Report & Daily Chart Pattern Signal Reports - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Does Xilio Therapeutics Inc. align with a passive investing strategy2025 Price Action Summary & Low Risk Investment Opportunities - thegnnews.com

Aug 16, 2025
pulisher
Aug 16, 2025

Xilio Therapeutics Second Quarter 2025 Earnings: US$0.16 loss per share (vs US$0.32 loss in 2Q 2024) - Yahoo Finance

Aug 16, 2025
pulisher
Aug 16, 2025

Analysts Offer Insights on Healthcare Companies: Lexeo Therapeutics, Inc. (LXEO), Clover Health Investments (CLOV) and Xilio Therapeutics (XLO) - The Globe and Mail

Aug 16, 2025
pulisher
Aug 15, 2025

Xilio Therapeutics, Inc. (XLO) Reports Q2 Loss, Misses Revenue Estimates - MSN

Aug 15, 2025
pulisher
Aug 15, 2025

Xilio Therapeutics shares fall 1.27% after-hours following Q2 pipeline progress and business updates. - AInvest

Aug 15, 2025
pulisher
Aug 15, 2025

Xilio Revenue Jumps 246 Percent in Q2 - AOL.com

Aug 15, 2025
pulisher
Aug 15, 2025

Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2025 Financial Results - MarketScreener

Aug 15, 2025
pulisher
Aug 15, 2025

Xilio Therapeutics 2025 Q2 Earnings Improved EPS Amid Wider Net Loss - AInvest

Aug 15, 2025
pulisher
Aug 14, 2025

Xilio Therapeutics Q2 Earnings Beat Expectations, Revenue Doubles to $8.084M. - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Xilio Therapeutics shares fall 2.52% intraday after announcing updated Phase 2 data for vilastobart. - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Xilio Therapeutics Reports Q2 Loss, Misses Revenue Estimates: Stock Expected to Underperform Market - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Xilio Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 14, 2025
pulisher
Aug 14, 2025

Xilio Therapeutics, Inc. SEC 10-Q Report - TradingView

Aug 14, 2025
pulisher
Aug 14, 2025

Xilio Therapeutics Q2 2025 Financial Results and Business Updates - TradingView

Aug 14, 2025
pulisher
Aug 14, 2025

Cancer Drug Breakthrough: Xilio's Vilastobart Delivers Strong Results with Fewer Side Effects - Stock Titan

Aug 14, 2025
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Kapitalisierung:     |  Volumen (24h):